FDA Inspection
Chinese Peptide CompanyChinese Peptide Company – FDA Inspection, Sep 4, 2026
Record Details
This FDA Inspection record concerns Chinese Peptide Company, with an inspection on September 4, 2026, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · f889fe40-7ad2-48d8-8257-c30bd3168400
Inspection Facts
- Inspection number
- 1339684
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Chinese Peptide Company
4| Date | Classification | Office | Project area |
|---|---|---|---|
| June 14, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 17, 2016 | NAI | Center for Devices and Radiological Health | Compliance: Devices |
| November 14, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 16, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Chinese Peptide Company
- FDA Inspection 1242852 - 2024-06-14
- FDA Inspection 967430 - 2016-03-17
- FDA Inspection 908354 - 2014-11-14
- FDA Inspection 774762 - 2012-02-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.